Platinum-resistant Recurrent Ovarian Cancer
Oncology
4 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Platinum-resistant Recurrent Ovarian Cancer?
BioSniper tracks 4 drugs in development for Platinum-resistant Recurrent Ovarian Cancer across 2 companies.
How many clinical trials target Platinum-resistant Recurrent Ovarian Cancer?
There are 1 clinical trial targeting Platinum-resistant Recurrent Ovarian Cancer tracked by BioSniper.
Analyze ASCENTAGE PHARMA GROUP INTERNATIONAL's Platinum-resistant Recurrent Ovarian Cancer pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company